Bristol-Myers Squibb Stock
Bristol-Myers Squibb Stock
Bristol-Myers Squibb gained 1.600% today.
Our community is currently high on Bristol-Myers Squibb with 10 Buy predictions and 3 Sell predictions.
With a target price of 65 € there is a positive potential of 43.25% for Bristol-Myers Squibb compared to the current price of 45.38 €.
Our community identified positive and negative aspects for Bristol-Myers Squibb stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bristol-Myers Squibb stock. On the other hand our users think that "Business model" could be a problem in the future.
Pros and Cons of Bristol-Myers Squibb in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bristol-Myers Squibb vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bristol-Myers Squibb | 1.600% | -0.982% | -4.974% | -29.102% | -2.209% | -16.941% | 11.747% |
| Pfizer Inc. | -0.020% | -2.851% | -6.654% | -35.541% | -8.621% | -25.863% | -28.239% |
| Elanco Animal Health Inc. | -0.380% | -7.271% | -12.163% | 50.047% | -5.666% | -49.025% | - |
| Biogen Inc. | -0.580% | -5.741% | -11.323% | -33.178% | -24.109% | -20.643% | -11.213% |
Comments
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Bank of America Co. from $72.00 to $68.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $81.00 to $69.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $56.00 to $50.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for BMY provided by MarketBeat